China Medical System (CMS, 867 HK) – A Cheap Play on China’s Pending Health Care Crisis
A derating as a result of a transition period creates an excellent investment opportunity in a market that desperately needs to increase healthcare...
618 Views
HK CEO & Director Dealings (29 May 2024): J&T Global, Melco, Techtronic, Gushengtang, United Energy
The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. These insights also flag those companies where...
386 Views
Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for March
The announcement of the inclusions to the HSI at the March rebalance will be made post market close today. Most stocks are trading lower which is...
1.1k Views
China Medical System (867 HK) - A Wise Choice in a Bear Market
CMS's performance low point is 2023/2024, but high growth returns in 2025. Despite bad image due to past financial fraud, high dividend/strong...
523 Views
Index Rebalance & ETF Flow Recap: HSI, LQ45, FXI, 2823 HK, SENSEX
This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...
901 Views